IBM Q2 revenue grows 1%, lowers full-year outlook amid sharp decline in mainframe sales

icon MarsBit
Share
This is the logo of the coin.
IBM
----
AI summary iconSummary
IBM reported Q2 revenue of $17.2 billion, a 1% year-over-year increase, with adjusted earnings per share at $2.93—both below estimates. The company lowered its full-year revenue growth forecast to 4%-5%, citing a 42% decline in Z-series mainframe sales. Infrastructure revenue fell 7%, while software sales rose 5%. IBM’s stock climbed 3% in after-hours trading, despite a profit warning issued a week earlier. Market outlook remains cautious as tech firms adapt to changing demand. Investors are advised to monitor altcoins amid broader market uncertainty.

Huoxing Finance reports that on July 23, IBM released its Q2 financial results, showing only 1% revenue growth for the quarter and lowering its full-year revenue outlook, as a sharp decline in mainframe sales weighed on performance. IBM’s Q2 revenue amounted to $17.2 billion, up approximately 1% year-over-year, with adjusted earnings per share of $2.93—both below expectations. The company revised its full-year revenue growth forecast from “over 5%” to “4% to 5%.” Revenue from the Z-series mainframes plunged 42% year-over-year, contributing to a 7% decline in infrastructure business. Software revenue remained relatively stable, increasing 5% year-over-year. Despite the results, IBM’s stock rose about 3% after hours, following a profit warning issued a week earlier.

Source:Show original
Disclaimer: The information on this page may have been obtained from third parties and does not necessarily reflect the views or opinions of KuCoin. This content is provided for general informational purposes only, without any representation or warranty of any kind, nor shall it be construed as financial or investment advice. KuCoin shall not be liable for any errors or omissions, or for any outcomes resulting from the use of this information. Investments in digital assets can be risky. Please carefully evaluate the risks of a product and your risk tolerance based on your own financial circumstances. For more information, please refer to our Terms of Use and Risk Disclosure.